Erratum: Psoriasis comorbidity management in the COVID era: a pressing challenge

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2024.1502059

IF: 5.2

2024-10-08

Frontiers in Microbiology

Abstract:This article is an erratum on: Psoriasis comorbidity management in the COVID era: a pressing challenge

microbiology

What problem does this paper attempt to address?

Corrigendum to Prevalence of Utilization Management Policies Among the Psoriatic Disease Community: Results From the 2019 National Psoriasis Foundation Advocacy Survey

DOI: https://doi.org/10.1177/24755303231195870

Abstract:[This corrects the article DOI: 10.1177/2475530320956602.].
Corrigendum to “Exploring comorbidity and pharmacological treatment patterns in psoriasis - A retrospective population-based cross-sectional study”

DOI: https://doi.org/10.1177/26335565231223601

2023-12-01

Journal of Multimorbidity and Comorbidity

Abstract:[This corrects the article DOI: 10.1177/26335565231212336.].
Corrigendum to Assessing the Effect of Demographic Background on Barriers to Seek Medical Attention for Psoriasis

DOI: https://doi.org/10.1177/24755303231195869

Abstract:[This corrects the article DOI: 10.1177/2475530320950265.].
Corrigendum to Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities

DOI: https://doi.org/10.1177/24755303231195867

Abstract:[This corrects the article DOI: 10.1177/24755303221131257.].
Erratum: Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1370893

IF: 7.3

2024-02-06

Frontiers in Immunology

Abstract:This article is an erratum on: Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention

immunology
Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

DOI: https://doi.org/10.1097/MS9.0000000000002497

2024-09-04

Abstract:[This corrects the article DOI: 10.1097/MS9.0000000000001601.].
Corrigendum to Likelihood of COVID-19 Vaccination Among Individuals Living With Psoriatic Disease: Results From a Large Real-World Survey

DOI: https://doi.org/10.1177/24755303231195873

Abstract:[This corrects the article DOI: 10.1177/24755303211067822.].
Corrigendum to Dosage Adjustments in Patients With Psoriasis on Etanercept: A Retrospective Chart Review

DOI: https://doi.org/10.1177/24755303231195871

Abstract:[This corrects the article DOI: 10.1177/2475530320910466.].
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg,Joseph F. Merola,Knut Schäkel,Luis Puig,Patrick D. Mahar,Isabella Yali Wang,Imre Pavo,Christopher Schuster,Christopher E. M. Griffiths

DOI: https://doi.org/10.3389/fmed.2023.1171132

IF: 3.9

2023-03-10

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.1092688.].

medicine, general & internal
Corrigendum to Acute Respiratory Distress Syndrome in a Carrier of an Interleukin-36 Receptor Antagonist Mutation With Generalized Pustular Psoriasis

DOI: https://doi.org/10.1177/24755303231195868

Abstract:[This corrects the article DOI: 10.1177/24755303211051724.].
Erratum: The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2023.1358874

IF: 5.2

2024-01-09

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2023.1264768.].

microbiology
Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis

DOI: https://doi.org/10.1177/24755303231195863

Abstract:[This corrects the article DOI: 10.1177/2475530320970530.].
Erratum: A systematic review and meta-analysis of neuroticism and anxiety during the COVID-19 pandemic

Frontiers Production Office

DOI: https://doi.org/10.3389/fpsyt.2024.1382413

IF: 4.7

2024-02-15

Frontiers in Psychiatry

Abstract:This article is an erratum on: A systematic review and meta-analysis of neuroticism and anxiety during the COVID-19 pandemic

psychiatry
Corrigendum to Remission of Recalcitrant Psoriasis on Combined Biologic Therapy With Infliximab and Ustekinumab

DOI: https://doi.org/10.1177/24755303231195884

Abstract:[This corrects the article DOI: 10.1177/24755303211029598.].
Corrigendum to Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series

DOI: https://doi.org/10.1177/24755303231195857

Abstract:[This corrects the article DOI: 10.1177/2475530321995516.].
Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series

DOI: https://doi.org/10.1177/24755303231195862

Abstract:[This corrects the article DOI: 10.1177/2475530320970538.].
Erratum: Addendum of Conflict of Interest

Journal Of Rheumatic Diseases Editorial Office

DOI: https://doi.org/10.4078/jrd.2023e1

2023-01-01

Abstract:[This corrects the article on p. 0 in vol. 0.].
Corrigendum to Retrospective Analysis in Patients With Moderate to Severe Plaque Psoriasis Treated With Tildrakizumab: Real-Life Clinical Data

DOI: https://doi.org/10.1177/24755303231195882

Abstract:[This corrects the article DOI: 10.1177/24755303221077211.].
Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

DOI: https://doi.org/10.1177/24755303231195874

Abstract:[This corrects the article DOI: 10.1177/24755303211056059.].
Erratum: The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study

Frontiers Production Office

DOI: https://doi.org/10.3389/fpubh.2024.1380811

IF: 5.2

2024-02-13

Frontiers in Public Health

Abstract:This article is an erratum on: The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study

public, environmental & occupational health

Erratum: Psoriasis comorbidity management in the COVID era: a pressing challenge

Corrigendum to Prevalence of Utilization Management Policies Among the Psoriatic Disease Community: Results From the 2019 National Psoriasis Foundation Advocacy Survey

Corrigendum to “Exploring comorbidity and pharmacological treatment patterns in psoriasis - A retrospective population-based cross-sectional study”

Corrigendum to Assessing the Effect of Demographic Background on Barriers to Seek Medical Attention for Psoriasis

Corrigendum to Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities

Erratum: Modifiable risk factors linked to the development of rheumatoid arthritis: evidence, immunological mechanisms and prevention

Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

Corrigendum to Likelihood of COVID-19 Vaccination Among Individuals Living With Psoriatic Disease: Results From a Large Real-World Survey

Corrigendum to Dosage Adjustments in Patients With Psoriasis on Etanercept: A Retrospective Chart Review

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Corrigendum to Acute Respiratory Distress Syndrome in a Carrier of an Interleukin-36 Receptor Antagonist Mutation With Generalized Pustular Psoriasis

Erratum: The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions

Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis

Erratum: A systematic review and meta-analysis of neuroticism and anxiety during the COVID-19 pandemic

Corrigendum to Remission of Recalcitrant Psoriasis on Combined Biologic Therapy With Infliximab and Ustekinumab

Corrigendum to Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series

Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series

Erratum: Addendum of Conflict of Interest

Corrigendum to Retrospective Analysis in Patients With Moderate to Severe Plaque Psoriasis Treated With Tildrakizumab: Real-Life Clinical Data

Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

Erratum: The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study